Tag: Lambdas

New England Journal of Medicine Publishes Positive Phase 3 TOGETHER Results with Peginterferon Lambda in COVID-19

–  Phase 3 TOGETHER data showed early treatment with a single dose of peginterferon lambda (Lambda) in patients with mild-to-moderate COVID-19 infections resulted in significantly decreased clinical events –  Lambda reduced risk of hospitalization or emergency room visits by 51% (primary endpoint) –  Lambda reduced risk of hospitalization by 42%…

Continue Reading New England Journal of Medicine Publishes Positive Phase 3 TOGETHER Results with Peginterferon Lambda in COVID-19